-
3
-
-
42949163491
-
Mechanisms of hepatic fibrogenesis
-
Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-1669
-
(2008)
Gastroenterology
, vol.134
, pp. 1655-1669
-
-
Friedman, S.L.1
-
4
-
-
54549119175
-
The global impact of hepatic fibrosis and end-stage liver disease
-
vii
-
Lim YS, Kim WR. The global impact of hepatic fibrosis and end-stage liver disease. Clin Liver Dis 2008;12:733-746, vii
-
(2008)
Clin Liver Dis
, vol.12
, pp. 733-746
-
-
Lim, Y.S.1
Kim, W.R.2
-
5
-
-
0035980914
-
Chronic liver injury, TGF-beta, and cancer
-
Bissell DM. Chronic liver injury, TGF-beta, and cancer. Exp Mol Med 2001;33:179-190
-
(2001)
Exp Mol Med
, vol.33
, pp. 179-190
-
-
Bissell, D.M.1
-
6
-
-
0034767501
-
Transforming growth factor beta and the liver
-
Bissell DM, Roulot D, George J. Transforming growth factor beta and the liver. Hepatol 2001;34:859-867
-
(2001)
Hepatol
, vol.34
, pp. 859-867
-
-
Bissell, D.M.1
Roulot, D.2
George, J.3
-
8
-
-
67651160595
-
Renin-angiotensin system in the pathogenesis of liver fibrosis
-
Pereira RM, dos Santos RA, da Costa Dias FL, Teixeira MM, Simoes e Silva AC. Renin-angiotensin system in the pathogenesis of liver fibrosis. W J Gastro 2009;15:2579-2586
-
(2009)
W J Gastro
, vol.15
, pp. 2579-2586
-
-
Pereira, R.M.1
dos Santos, R.A.2
da Costa Dias, F.L.3
Teixeira, M.M.4
Simoes e Silva, A.C.5
-
9
-
-
81755163663
-
Hepatic fibrosis and the renin-angiotensin system
-
Epub ahead at print
-
Abbas G, Silveira MG, Lindor KD. Hepatic fibrosis and the renin-angiotensin system. Am J Ther [Epub ahead at print]
-
Am J Ther
-
-
Abbas, G.1
Silveira, M.G.2
Lindor, K.D.3
-
10
-
-
0037772442
-
Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II
-
Bataller R, Sancho-Bru P, Gines P, Lora JM, Al-Garawi A, Sole M, Colmenero J, Nicolas JM, Jimenez W, Weich N, Gutierrez-Ramos JC, Arroyo V, Rodes J. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 2003;125:117-125
-
(2003)
Gastroenterology
, vol.125
, pp. 117-125
-
-
Bataller, R.1
Sancho-Bru, P.2
Gines, P.3
Lora, J.M.4
Al-Garawi, A.5
Sole, M.6
Colmenero, J.7
Nicolas, J.M.8
Jimenez, W.9
Weich, N.10
Gutierrez-Ramos, J.C.11
Arroyo, V.12
Rodes, J.13
-
11
-
-
0034961836
-
Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis
-
Jonsson JR, Clouston AD, Ando Y, Kelemen LI, Horn MJ, Adamson MD, Purdie DM, Powell EE. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 2001;121:148-155
-
(2001)
Gastroenterology
, vol.121
, pp. 148-155
-
-
Jonsson, J.R.1
Clouston, A.D.2
Ando, Y.3
Kelemen, L.I.4
Horn, M.J.5
Adamson, M.D.6
Purdie, D.M.7
Powell, E.E.8
-
12
-
-
0042168915
-
An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells
-
Kurikawa N, Suga M, Kuroda S, Yamada K, Ishikawa H. An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells. Br J Pharmacol 2003;139:1085-1094
-
(2003)
Br J Pharmacol
, vol.139
, pp. 1085-1094
-
-
Kurikawa, N.1
Suga, M.2
Kuroda, S.3
Yamada, K.4
Ishikawa, H.5
-
13
-
-
0041347547
-
AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl(4)
-
Kanno K, Tazuma S, Chayama K. AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl(4). Biochem Biophys Res Commun 2003;308:177-183
-
(2003)
Biochem Biophys Res Commun
, vol.308
, pp. 177-183
-
-
Kanno, K.1
Tazuma, S.2
Chayama, K.3
-
14
-
-
0034807564
-
Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in rats
-
Ohishi T, Saito H, Tsusaka K, Toda K, Inagaki H, Hamada Y, Kumagai N, Atsukawa K, Ishii H. Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in rats. Hepatol Res 2001;21:147-158
-
(2001)
Hepatol Res
, vol.21
, pp. 147-158
-
-
Ohishi, T.1
Saito, H.2
Tsusaka, K.3
Toda, K.4
Inagaki, H.5
Hamada, Y.6
Kumagai, N.7
Atsukawa, K.8
Ishii, H.9
-
15
-
-
0034849945
-
Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis
-
Paizis G, Gilbert RE, Cooper ME, Murthi P, Schembri JM, Wu LL, Rumble JR, Kelly DJ, Tikellis C, Cox A, Smallwood RA, Angus PW. Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol 2001;35:376-385
-
(2001)
J Hepatol
, vol.35
, pp. 376-385
-
-
Paizis, G.1
Gilbert, R.E.2
Cooper, M.E.3
Murthi, P.4
Schembri, J.M.5
Wu, L.L.6
Rumble, J.R.7
Kelly, D.J.8
Tikellis, C.9
Cox, A.10
Smallwood, R.A.11
Angus, P.W.12
-
16
-
-
33750988751
-
Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats
-
Ueki M, Koda M, Yamamoto S, Matsunaga Y, Murawaki Y. Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats. J Gastroenterol 2006;41:996-1004
-
(2006)
J Gastroenterol
, vol.41
, pp. 996-1004
-
-
Ueki, M.1
Koda, M.2
Yamamoto, S.3
Matsunaga, Y.4
Murawaki, Y.5
-
17
-
-
21844457440
-
Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice
-
Yang L, Bataller R, Dulyx J, Coffman TM, Gines P, Rippe RA, Brenner DA. Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice. J Hepatol 2005;43:317-323
-
(2005)
J Hepatol
, vol.43
, pp. 317-323
-
-
Yang, L.1
Bataller, R.2
Dulyx, J.3
Coffman, T.M.4
Gines, P.5
Rippe, R.A.6
Brenner, D.A.7
-
18
-
-
0035991447
-
Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats
-
Yoshiji H, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Imazu H, Yanase K, Kuriyama S, Fukui H. Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats. J Hepatol 2002;37:22-30
-
(2002)
J Hepatol
, vol.37
, pp. 22-30
-
-
Yoshiji, H.1
Yoshii, J.2
Ikenaka, Y.3
Noguchi, R.4
Tsujinoue, H.5
Nakatani, T.6
Imazu, H.7
Yanase, K.8
Kuriyama, S.9
Fukui, H.10
-
19
-
-
42949086433
-
Cellular and molecular mechanisms of liver injury
-
Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008;134:1641-1654
-
(2008)
Gastroenterology
, vol.134
, pp. 1641-1654
-
-
Malhi, H.1
Gores, G.J.2
-
20
-
-
0037221910
-
Liver fibrosis: Insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors
-
Yang C, Zeisberg M, Mosterman B, Sudhakar A, Yerramalla U, Holthaus K, Xu L, Eng F, Afdhal N, Kalluri R. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 2003;124:147-159
-
(2003)
Gastroenterology
, vol.124
, pp. 147-159
-
-
Yang, C.1
Zeisberg, M.2
Mosterman, B.3
Sudhakar, A.4
Yerramalla, U.5
Holthaus, K.6
Xu, L.7
Eng, F.8
Afdhal, N.9
Kalluri, R.10
-
21
-
-
84856401734
-
Liver fibrosis: Signals leading to the amplification of the fibrogenic hepatic stellate cell
-
Gabele E, Brenner DA, Rippe RA. Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci 2003;8:d69-d77
-
(2003)
Front Biosci
, vol.8
-
-
Gabele, E.1
Brenner, D.A.2
Rippe, R.A.3
-
22
-
-
61949395894
-
Cholangiocyte proliferation and liver fibrosis
-
Glaser SS, Gaudio E, Miller T, Alvaro D, Alpini G. Cholangiocyte proliferation and liver fibrosis. Expert Rev Mol Med 2009;11:e7
-
(2009)
Expert Rev Mol Med
, vol.11
-
-
Glaser, S.S.1
Gaudio, E.2
Miller, T.3
Alvaro, D.4
Alpini, G.5
-
23
-
-
33846205222
-
Proliferating cholangiocytes: A neuroendocrine compartment in the diseased liver
-
Alvaro D, Mancino MG, Glaser S, Gaudio E, Marzioni M, Francis H, Alpini G. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology 2007;132:415-431
-
(2007)
Gastroenterology
, vol.132
, pp. 415-431
-
-
Alvaro, D.1
Mancino, M.G.2
Glaser, S.3
Gaudio, E.4
Marzioni, M.5
Francis, H.6
Alpini, G.7
-
24
-
-
33846205222
-
Proliferating cholangiocytes: A neuroendocrine compartment in the diseased liver
-
Alvaro D, Mancino MG, Glaser S, Gaudio E, Marzioni M, Francis H, Alpini G. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology 2007;132:415-431
-
(2007)
Gastroenterology
, vol.132
, pp. 415-431
-
-
Alvaro, D.1
Mancino, M.G.2
Glaser, S.3
Gaudio, E.4
Marzioni, M.5
Francis, H.6
Alpini, G.7
-
26
-
-
0000227058
-
The pathobiology of biliary epithelia
-
In: Arias EIM, Boyer JL, Chisari FV, Fausto N, Jakoby W, Schachter D, Shafritz DA, eds., Philadelphia, PA: Lippincott Williams & Wilkins
-
Alpini G, Prall RT, LaRusso NF. The pathobiology of biliary epithelia. In: Arias EIM, Boyer JL, Chisari FV, Fausto N, Jakoby W, Schachter D, Shafritz DA, eds. The Liver; Biology & Pathobiology. Philadelphia, PA: Lippincott Williams & Wilkins, 2001:421-435
-
(2001)
The Liver; Biology & Pathobiology
, pp. 421-435
-
-
Alpini, G.1
Prall, R.T.2
Larusso, N.F.3
-
28
-
-
0035066961
-
Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis
-
Sedlaczek N, Jia JD, Bauer M, Herbst H, Ruehl M, Hahn EG, Schuppan D. Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. Am J Pathol 2001;158:1239-1244
-
(2001)
Am J Pathol
, vol.158
, pp. 1239-1244
-
-
Sedlaczek, N.1
Jia, J.D.2
Bauer, M.3
Herbst, H.4
Ruehl, M.5
Hahn, E.G.6
Schuppan, D.7
-
29
-
-
0026320289
-
Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease
-
Milani S, Herbst H, Schuppan D, Stein H, Surrenti C. Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol 1991;139:1221-1229
-
(1991)
Am J Pathol
, vol.139
, pp. 1221-1229
-
-
Milani, S.1
Herbst, H.2
Schuppan, D.3
Stein, H.4
Surrenti, C.5
-
30
-
-
23244434070
-
Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome
-
Luo B, Tang L, Wang Z, Zhang J, Ling Y, Feng W, Sun JZ, Stockard CR, Frost AR, Chen YF, Grizzle WE, Fallon MB. Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome. Gastroenterology 2005;129:682-695
-
(2005)
Gastroenterology
, vol.129
, pp. 682-695
-
-
Luo, B.1
Tang, L.2
Wang, Z.3
Zhang, J.4
Ling, Y.5
Feng, W.6
Sun, J.Z.7
Stockard, C.R.8
Frost, A.R.9
Chen, Y.F.10
Grizzle, W.E.11
Fallon, M.B.12
-
31
-
-
0034120477
-
An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis
-
Cho JJ, Hocher B, Herbst H, Jia JD, Ruehl M, Hahn EG, Riecken EO, Schuppan D. An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis. Gastroenterology 2000;118:1169-1178
-
(2000)
Gastroenterology
, vol.118
, pp. 1169-1178
-
-
Cho, J.J.1
Hocher, B.2
Herbst, H.3
Jia, J.D.4
Ruehl, M.5
Hahn, E.G.6
Riecken, E.O.7
Schuppan, D.8
-
32
-
-
33947174603
-
The renin-angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-(1-7)
-
Pereira RM, Dos Santos RA, Teixeira MM, Leite VH, Costa LP, da Costa Dias FL, Barcelos LS, Collares GB, Simoes e Silva AC. The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of Angiotensin-(1-7). J Hepatol 2007;46:674-681
-
(2007)
J Hepatol
, vol.46
, pp. 674-681
-
-
Pereira, R.M.1
dos Santos, R.A.2
Teixeira, M.M.3
Leite, V.H.4
Costa, L.P.5
da Costa Dias, F.L.6
Barcelos, L.S.7
Collares, G.B.8
Simoes e Silva, A.C.9
-
33
-
-
77950477513
-
Additive antifibrotic effects of pioglitazone and candesartan on experimental renal fibrosis in mice
-
Higashi K, Oda T, Kushiyama T, Hyodo T, Yamada M, Suzuki S, Sakurai Y, Miura S, Kumagai H. Additive antifibrotic effects of pioglitazone and candesartan on experimental renal fibrosis in mice. Nephrology (Carlton) 2010;15:327-335
-
(2010)
Nephrology (Carlton)
, vol.15
, pp. 327-335
-
-
Higashi, K.1
Oda, T.2
Kushiyama, T.3
Hyodo, T.4
Yamada, M.5
Suzuki, S.6
Sakurai, Y.7
Miura, S.8
Kumagai, H.9
-
34
-
-
79451475323
-
Atrial fibrillation induces myocardial fibrosis through angiotensin II Type 1 receptor-specific arkadia-mediated downregulation of Smad7
-
He X, Gao X, Peng L, Wang S, Zhu Y, Ma H, Lin J, Duan DD. Atrial fibrillation induces myocardial fibrosis through angiotensin II Type 1 receptor-specific arkadia-mediated downregulation of Smad7. Circ Res 2011;108:164-175
-
(2011)
Circ Res
, vol.108
, pp. 164-175
-
-
He, X.1
Gao, X.2
Peng, L.3
Wang, S.4
Zhu, Y.5
Ma, H.6
Lin, J.7
Duan, D.D.8
-
35
-
-
17844403732
-
Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats
-
Bataller R, Gabele E, Parsons CJ, Morris T, Yang L, Schoonhoven R, Brenner DA, Rippe RA. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats. Hepatol 2005;41:1046-1055
-
(2005)
Hepatol
, vol.41
, pp. 1046-1055
-
-
Bataller, R.1
Gabele, E.2
Parsons, C.J.3
Morris, T.4
Yang, L.5
Schoonhoven, R.6
Brenner, D.A.7
Rippe, R.A.8
-
36
-
-
0037901037
-
Minireview: Overview of the renin- angiotensin system - an endocrine and paracrine system
-
Lavoie JL, Sigmund CD. Minireview: overview of the renin- angiotensin system - an endocrine and paracrine system. Endocrinology 2003;144:2179-2183
-
(2003)
Endocrinology
, vol.144
, pp. 2179-2183
-
-
Lavoie, J.L.1
Sigmund, C.D.2
-
37
-
-
0034121853
-
Regulation of renin: New evidence from cultured cells and genetically modified mice
-
Bader M, Ganten D. Regulation of renin: new evidence from cultured cells and genetically modified mice. J Mol Med 2000;78:130-139
-
(2000)
J Mol Med
, vol.78
, pp. 130-139
-
-
Bader, M.1
Ganten, D.2
-
38
-
-
0030874825
-
Molecular genetics of human hypertension: Role of angiotensinogen
-
Corvol P, Jeunemaitre X. Molecular genetics of human hypertension: role of angiotensinogen. Endocr Rev 1997;18:662-677
-
(1997)
Endocr Rev
, vol.18
, pp. 662-677
-
-
Corvol, P.1
Jeunemaitre, X.2
-
39
-
-
0021752503
-
Local generation of angiotensin II as a mechanism of regulation of peripheral vascular tone in the rat
-
Oliver JA, Sciacca RR. Local generation of angiotensin II as a mechanism of regulation of peripheral vascular tone in the rat. J Clin Invest 1984;74:1247-1251
-
(1984)
J Clin Invest
, vol.74
, pp. 1247-1251
-
-
Oliver, J.A.1
Sciacca, R.R.2
-
40
-
-
0029550132
-
Mechanisms of angiotensin II formation in humans
-
Urata H, Nishimura H, Ganten D. Mechanisms of angiotensin II formation in humans. Eur Heart J 1995;16 (Suppl N):79-85
-
(1995)
Eur Heart J
, vol.16
, Issue.SUPPL. N
, pp. 79-85
-
-
Urata, H.1
Nishimura, H.2
Ganten, D.3
-
41
-
-
33745845825
-
Physiology of local renin-angiotensin systems
-
Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006;86:747-803
-
(2006)
Physiol Rev
, vol.86
, pp. 747-803
-
-
Paul, M.1
Poyan, M.A.2
Kreutz, R.3
-
42
-
-
43449134667
-
Update on tissue renin-angiotensin systems
-
Bader M, Ganten D. Update on tissue renin-angiotensin systems. J Mol Med 2008;86:615-621
-
(2008)
J Mol Med
, vol.86
, pp. 615-621
-
-
Bader, M.1
Ganten, D.2
-
43
-
-
34247113814
-
Angiotensin II signal transduction through the AT1 receptor: Novel insights into mechanisms and pathophysiology
-
Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD, Eguchi S. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 2007;112:417-428
-
(2007)
Clin Sci (Lond)
, vol.112
, pp. 417-428
-
-
Higuchi, S.1
Ohtsu, H.2
Suzuki, H.3
Shirai, H.4
Frank, G.D.5
Eguchi, S.6
-
44
-
-
33846362954
-
Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system
-
Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292:C82-C97
-
(2007)
Am J Physiol Cell Physiol
, vol.292
-
-
Mehta, P.K.1
Griendling, K.K.2
-
45
-
-
0034705472
-
Cytokine actions of angiotensin II
-
Sadoshima J. Cytokine actions of angiotensin II. Circ Res 2000;86: 1187-1189
-
(2000)
Circ Res
, vol.86
, pp. 1187-1189
-
-
Sadoshima, J.1
-
46
-
-
0022444188
-
Biological activities of angiotensin II-(1-6)-hexapeptide and angiotensin II-(1-7)-heptapeptide in man
-
Kono T, Taniguchi A, Imura H, Oseko F, Khosla MC. Biological activities of angiotensin II-(1-6)-hexapeptide and angiotensin II-(1-7)-heptapeptide in man. Life Sci 1986;38:1515-1519
-
(1986)
Life Sci
, vol.38
, pp. 1515-1519
-
-
Kono, T.1
Taniguchi, A.2
Imura, H.3
Oseko, F.4
Khosla, M.C.5
-
47
-
-
0020640185
-
Proteolytic conversion of angiotensins in rat brain tissue
-
Tonnaer JA, Engels GM, Wiegant VM, Burbach JP, De Jong W, De Wied D. Proteolytic conversion of angiotensins in rat brain tissue. Eur J Biochem 1983;131:415-421
-
(1983)
Eur J Biochem
, vol.131
, pp. 415-421
-
-
Tonnaer, J.A.1
Engels, G.M.2
Wiegant, V.M.3
Burbach, J.P.4
de Jong, W.5
de Wied, D.6
-
48
-
-
0019205756
-
Identification of an angiotensin receptor in rabbit renomedullary interstitial cells in tissue culture. Correlation with prostaglandin biosynthesis
-
Brown CA, Zusman RM, Haber E. Identification of an angiotensin receptor in rabbit renomedullary interstitial cells in tissue culture. Correlation with prostaglandin biosynthesis. Circ Res 1980;46:802-807
-
(1980)
Circ Res
, vol.46
, pp. 802-807
-
-
Brown, C.A.1
Zusman, R.M.2
Haber, E.3
-
49
-
-
0025137039
-
Biological activity of angiotensin-(1-7) heptapeptide in the hamster heart
-
Kumagai H, Khosla M, Ferrario C, Fouad-Tarazi FM. Biological activity of angiotensin-(1-7) heptapeptide in the hamster heart. Hypertens 1990;15:I29-I33
-
(1990)
Hypertens
, vol.15
-
-
Kumagai, H.1
Khosla, M.2
Ferrario, C.3
Fouad-Tarazi, F.M.4
-
50
-
-
0031045996
-
Active fragments of angiotensin II: Enzymatic pathways of synthesis and biological effects
-
Ardaillou R. Active fragments of angiotensin II: enzymatic pathways of synthesis and biological effects. Curr Opin Nephrol Hypertens 1997;6:28-34
-
(1997)
Curr Opin Nephrol Hypertens
, vol.6
, pp. 28-34
-
-
Ardaillou, R.1
-
51
-
-
33846244600
-
The physiological significance of the alternative pathways of angiotensin II production
-
Kramkowski K, Mogielnicki A, Buczko W. The physiological significance of the alternative pathways of angiotensin II production. J Physiol Pharmacol 2006;57:529-539
-
(2006)
J Physiol Pharmacol
, vol.57
, pp. 529-539
-
-
Kramkowski, K.1
Mogielnicki, A.2
Buczko, W.3
-
52
-
-
0038053724
-
A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9
-
Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000;87:E1-E9
-
(2000)
Circ Res
, vol.87
-
-
Donoghue, M.1
Hsieh, F.2
Baronas, E.3
Godbout, K.4
Gosselin, M.5
Stagliano, N.6
Donovan, M.7
Woolf, B.8
Robison, K.9
Jeyaseelan, R.10
Breitbart, R.E.11
Acton, S.12
-
53
-
-
0034721906
-
A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase
-
Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000;275:33238-33243
-
(2000)
J Biol Chem
, vol.275
, pp. 33238-33243
-
-
Tipnis, S.R.1
Hooper, N.M.2
Hyde, R.3
Karran, E.4
Christie, G.5
Turner, A.J.6
-
54
-
-
0037478671
-
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas
-
Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 2003;100:8258-8263
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 8258-8263
-
-
Santos, R.A.1
Simoes e Silva, A.C.2
Maric, C.3
Silva, D.M.4
Machado, R.P.5
de Buhr, I.6
Heringer-Walther, S.7
Pinheiro, S.V.8
Lopes, M.T.9
Bader, M.10
Mendes, E.P.11
Lemos, V.S.12
Campagnole-Santos, M.J.13
Schultheiss, H.P.14
Speth, R.15
Walther, T.16
-
55
-
-
67650541842
-
Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis versus ACE2-angiotensin-(1-7)-Mas receptor axis
-
Iwai M, Horiuchi M. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis versus ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res 2009;32:533-536
-
(2009)
Hypertens Res
, vol.32
, pp. 533-536
-
-
Iwai, M.1
Horiuchi, M.2
-
56
-
-
77951101164
-
New pathways of the renin-angiotensin system: The role of ACE2 in cardiovascular pathophysiology and therapy
-
Castro-Chaves P, Cerqueira R, Pintalhao M, Leite-Moreira AF. New pathways of the renin-angiotensin system: the role of ACE2 in cardiovascular pathophysiology and therapy. Expert Opin Ther Targets 2010;14:485-496
-
(2010)
Expert Opin Ther Targets
, vol.14
, pp. 485-496
-
-
Castro-Chaves, P.1
Cerqueira, R.2
Pintalhao, M.3
Leite-Moreira, A.F.4
-
57
-
-
6344246036
-
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism
-
Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 2004;383:45-51
-
(2004)
Biochem J
, vol.383
, pp. 45-51
-
-
Rice, G.I.1
Thomas, D.A.2
Grant, P.J.3
Turner, A.J.4
Hooper, N.M.5
-
58
-
-
18544378161
-
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase
-
Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, Acton S, Patane M, Nichols A, Tummino P. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002;277:14838-14843
-
(2002)
J Biol Chem
, vol.277
, pp. 14838-14843
-
-
Vickers, C.1
Hales, P.2
Kaushik, V.3
Dick, L.4
Gavin, J.5
Tang, J.6
Godbout, K.7
Parsons, T.8
Baronas, E.9
Hsieh, F.10
Acton, S.11
Patane, M.12
Nichols, A.13
Tummino, P.14
-
59
-
-
24344509196
-
The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of Mas-knockout mice
-
Lemos VS, Silva DM, Walther T, Alenina N, Bader M, Santos RA. The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of Mas-knockout mice. J Cardiovasc Pharmacol 2005;46:274-279
-
(2005)
J Cardiovasc Pharmacol
, vol.46
, pp. 274-279
-
-
Lemos, V.S.1
Silva, D.M.2
Walther, T.3
Alenina, N.4
Bader, M.5
Santos, R.A.6
-
60
-
-
25444473110
-
Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the Mas receptor
-
Tallant EA, Ferrario CM, Gallagher PE. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the Mas receptor. Am J Physiol Heart Circ Physiol 2005;289:H1560-H1566
-
(2005)
Am J Physiol Heart Circ Physiol
, vol.289
-
-
Tallant, E.A.1
Ferrario, C.M.2
Gallagher, P.E.3
-
61
-
-
0034120267
-
Angiotensin II induces contraction and proliferation of human hepatic stellate cells
-
Bataller R, Gines P, Nicolas JM, Gorbig MN, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V, Rodes J. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 2000;118:1149-1156
-
(2000)
Gastroenterology
, vol.118
, pp. 1149-1156
-
-
Bataller, R.1
Gines, P.2
Nicolas, J.M.3
Gorbig, M.N.4
Garcia-Ramallo, E.5
Gasull, X.6
Bosch, J.7
Arroyo, V.8
Rodes, J.9
-
62
-
-
0036830185
-
Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver
-
Paizis G, Cooper ME, Schembri JM, Tikellis C, Burrell LM, Angus PW. Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 2002;123:1667-1676
-
(2002)
Gastroenterology
, vol.123
, pp. 1667-1676
-
-
Paizis, G.1
Cooper, M.E.2
Schembri, J.M.3
Tikellis, C.4
Burrell, L.M.5
Angus, P.W.6
-
63
-
-
0242298260
-
Expression and localization of AT1 receptors in hepatic Kupffer cells: Its potential role in regulating a fibrogenic response
-
Leung PS, Suen PM, Ip SP, Yip CK, Chen G, Lai PB. Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response. Regul Pept 2003;116:61-69
-
(2003)
Regul Pept
, vol.116
, pp. 61-69
-
-
Leung, P.S.1
Suen, P.M.2
Ip, S.P.3
Yip, C.K.4
Chen, G.5
Lai, P.B.6
-
64
-
-
59849102311
-
Hepatocyte expression of angiotensin II type 1 receptor is downregulated in advanced human liver fibrosis
-
Schulte S, Oidtmann A, Kociok N, Demir M, Odenthal M, Drebber U, Dienes HP, Nierhoff D, Goeser T, Toex U, Steffen HM. Hepatocyte expression of angiotensin II type 1 receptor is downregulated in advanced human liver fibrosis. Liver Int 2009;29:384-391
-
(2009)
Liver Int
, vol.29
, pp. 384-391
-
-
Schulte, S.1
Oidtmann, A.2
Kociok, N.3
Demir, M.4
Odenthal, M.5
Drebber, U.6
Dienes, H.P.7
Nierhoff, D.8
Goeser, T.9
Toex, U.10
Steffen, H.M.11
-
65
-
-
34547410910
-
Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis
-
Herath CB, Warner FJ, Lubel JS, Dean RG, Jia Z, Lew RA, Smith AI, Burrell LM, Angus PW. Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J Hepatol 2007;47:387-395
-
(2007)
J Hepatol
, vol.47
, pp. 387-395
-
-
Herath, C.B.1
Warner, F.J.2
Lubel, J.S.3
Dean, R.G.4
Jia, Z.5
Lew, R.A.6
Smith, A.I.7
Burrell, L.M.8
Angus, P.W.9
-
66
-
-
67649496959
-
Expression of angiotensin-converting enzyme 2 in CCL4-induced rat liver fibrosis
-
Huang Q, Xie Q, Shi CC, Xiang XG, Lin LY, Gong BD, Zhao GD, Wang H, Jia NN. Expression of angiotensin-converting enzyme 2 in CCL4-induced rat liver fibrosis. Int J Mol Med 2009;23:717-723
-
(2009)
Int J Mol Med
, vol.23
, pp. 717-723
-
-
Huang, Q.1
Xie, Q.2
Shi, C.C.3
Xiang, X.G.4
Lin, L.Y.5
Gong, B.D.6
Zhao, G.D.7
Wang, H.8
Jia, N.N.9
-
67
-
-
28144453548
-
Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2
-
Paizis G, Tikellis C, Cooper ME, Schembri JM, Lew RA, Smith AI, Shaw T, Warner FJ, Zuilli A, Burrell LM, Angus PW. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 2005;54:1790-1796
-
(2005)
Gut
, vol.54
, pp. 1790-1796
-
-
Paizis, G.1
Tikellis, C.2
Cooper, M.E.3
Schembri, J.M.4
Lew, R.A.5
Smith, A.I.6
Shaw, T.7
Warner, F.J.8
Zuilli, A.9
Burrell, L.M.10
Angus, P.W.11
-
68
-
-
74049134978
-
Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors
-
Huang ML, Li X, Meng Y, Xiao B, Ma Q, Ying SS, Wu PS, Zhang ZS. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors. Clin Exp Pharmacol Physiol 2010;37:e1-e6
-
(2010)
Clin Exp Pharmacol Physiol
, vol.37
-
-
Huang, M.L.1
Li, X.2
Meng, Y.3
Xiao, B.4
Ma, Q.5
Ying, S.S.6
Wu, P.S.7
Zhang, Z.S.8
-
69
-
-
0018648008
-
Localization of angiotensinogen in rat liver by immunocytochemistry
-
Morris BJ, Iwamoto HS, Reid IA. Localization of angiotensinogen in rat liver by immunocytochemistry. Endocrinology 1979;105:796-800
-
(1979)
Endocrinology
, vol.105
, pp. 796-800
-
-
Morris, B.J.1
Iwamoto, H.S.2
Reid, I.A.3
-
70
-
-
0025397019
-
Angiotensinogen: Gene expression and protein localization in human tissues
-
Sawa H. Angiotensinogen: gene expression and protein localization in human tissues. Hokkaido Igaku Zasshi 1990;65:189-199
-
(1990)
Hokkaido Igaku Zasshi
, vol.65
, pp. 189-199
-
-
Sawa, H.1
-
71
-
-
0018915843
-
Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis
-
Bosch J, Arroyo V, Betriu A, Mas A, Carrilho F, Rivera F, Navarro-Lopez F, Rodes J. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology 1980;78:92-99
-
(1980)
Gastroenterology
, vol.78
, pp. 92-99
-
-
Bosch, J.1
Arroyo, V.2
Betriu, A.3
Mas, A.4
Carrilho, F.5
Rivera, F.6
Navarro-Lopez, F.7
Rodes, J.8
-
73
-
-
0029131135
-
Interrelationships between systemic hemodynamics, urinary sodium excretion, and renin-angiotensin system in cirrhosis
-
Aliaga L, Zozoya JM, Omar M, Mediavilla JD, Prieto J. Interrelationships between systemic hemodynamics, urinary sodium excretion, and renin-angiotensin system in cirrhosis. Acta Gastroenterol Belg 1995;58:213-221
-
(1995)
Acta Gastroenterol Belg
, vol.58
, pp. 213-221
-
-
Aliaga, L.1
Zozoya, J.M.2
Omar, M.3
Mediavilla, J.D.4
Prieto, J.5
-
74
-
-
64049091375
-
Effect of propranolol on the splanchnic and peripheral renin-angiotensin system in cirrhotic patients
-
Vilas-Boas WW, Ribeiro-Oliveira A Jr., Ribeiro Rda C, Vieira RL, Almeida J, Nadu AP, Simoes e Silva AC, Santos RA. Effect of propranolol on the splanchnic and peripheral renin-angiotensin system in cirrhotic patients. W J Gastro 2008;14:6824-6830
-
(2008)
W J Gastro
, vol.14
, pp. 6824-6830
-
-
Vilas-Boas, W.W.1
Ribeiro-Oliveira Jr., A.2
Ribeiro, R.C.3
Vieira, R.L.4
Almeida, J.5
Nadu, A.P.6
Simoes e Silva, A.C.7
Santos, R.A.8
-
75
-
-
67650156484
-
Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis
-
Vilas-Boas WW, Ribeiro-Oliveira A Jr., Pereira RM, Ribeiro Rda C, Almeida J, Nadu AP, Simoes e Silva AC, dos Santos RA. Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis. W J Gastro 2009;15:2512-2519
-
(2009)
W J Gastro
, vol.15
, pp. 2512-2519
-
-
Vilas-Boas, W.W.1
Ribeiro-Oliveira Jr., A.2
Pereira, R.M.3
Ribeiro, R.C.4
Almeida, J.5
Nadu, A.P.6
Simoes e Silva, A.C.7
dos Santos, R.A.8
-
76
-
-
0042009848
-
Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver
-
Bataller R, Gabele E, Schoonhoven R, Morris T, Lehnert M, Yang L, Brenner DA, Rippe RA. Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver. Am J Physiol Gastrointest Liver Physiol 2003;285:G642-G651
-
(2003)
Am J Physiol Gastrointest Liver Physiol
, vol.285
-
-
Bataller, R.1
Gabele, E.2
Schoonhoven, R.3
Morris, T.4
Lehnert, M.5
Yang, L.6
Brenner, D.A.7
Rippe, R.A.8
-
78
-
-
70349251728
-
Effects of AT1- and beta-adrenergic receptor antagonists on TGF-beta1-induced fibrosis in transgenic mice
-
Seeland U, Schaffer A, Selejan S, Hohl M, Reil JC, Muller P, Rosenkranz S, Bohm M. Effects of AT1- and beta-adrenergic receptor antagonists on TGF-beta1-induced fibrosis in transgenic mice. Eur J Clin Invest 2009;39:851-859
-
(2009)
Eur J Clin Invest
, vol.39
, pp. 851-859
-
-
Seeland, U.1
Schaffer, A.2
Selejan, S.3
Hohl, M.4
Reil, J.C.5
Muller, P.6
Rosenkranz, S.7
Bohm, M.8
-
79
-
-
0034802566
-
Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats
-
Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatol 2001;34:745-750
-
(2001)
Hepatol
, vol.34
, pp. 745-750
-
-
Yoshiji, H.1
Kuriyama, S.2
Yoshii, J.3
Ikenaka, Y.4
Noguchi, R.5
Nakatani, T.6
Tsujinoue, H.7
Fukui, H.8
-
80
-
-
38149078717
-
Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats
-
El-Demerdash E, Salam OM, El-Batran SA, Abdallah HM, Shaffie NM. Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats. Clin Exp Pharmacol Physiol 2008;35:159-167
-
(2008)
Clin Exp Pharmacol Physiol
, vol.35
, pp. 159-167
-
-
El-Demerdash, E.1
Salam, O.M.2
El-Batran, S.A.3
Abdallah, H.M.4
Shaffie, N.M.5
-
81
-
-
5044219699
-
Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats
-
Wei YH, Jun L, Qiang CJ. Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats. Dig Dis Sci 2004;49:1589-1594
-
(2004)
Dig Dis Sci
, vol.49
, pp. 1589-1594
-
-
Wei, Y.H.1
Jun, L.2
Qiang, C.J.3
-
82
-
-
0036827163
-
Effect of losartan, an angiotensin II antagonist, on secondary biliary cirrhosis
-
Ramalho LN, Ramalho FS, Zucoloto S, Castro-e-Silva Junior O, Correa FM, Elias Junior J, Magalhaes JF. Effect of losartan, an angiotensin II antagonist, on secondary biliary cirrhosis. Hepatogastro 2002;49:1499-1502
-
(2002)
Hepatogastro
, vol.49
, pp. 1499-1502
-
-
Ramalho, L.N.1
Ramalho, F.S.2
Zucoloto, S.3
Castro-e-Silva Jr., O.4
Correa, F.M.5
Elias Jr., J.6
Magalhaes, J.F.7
-
83
-
-
0034529716
-
The regulatory role of AT 1 receptor on activated HSCs in hepatic fibrogenesis:Effects of RAS inhibitors on hepatic fibrosis induced by CCl(4)
-
Wei HS, Lu HM, Li DG, Zhan YT, Wang ZR, Huang X, Cheng JL, Xu QF. The regulatory role of AT 1 receptor on activated HSCs in hepatic fibrogenesis:effects of RAS inhibitors on hepatic fibrosis induced by CCl(4). W J Gastro 2000;6:824-828
-
(2000)
W J Gastro
, vol.6
, pp. 824-828
-
-
Wei, H.S.1
Lu, H.M.2
Li, D.G.3
Zhan, Y.T.4
Wang, Z.R.5
Huang, X.6
Cheng, J.L.7
Xu, Q.F.8
-
84
-
-
56649106258
-
Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model
-
Kim MY, Baik SK, Park DH, Jang YO, Suk KT, Yea CJ, Lee IY, Kim JW, Kim HS, Kwon SO, Cho MY, Ko SB, Chang SJ, Um SH, Han KH. Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model. J Gastro 2008;43:889-896
-
(2008)
J Gastro
, vol.43
, pp. 889-896
-
-
Kim, M.Y.1
Baik, S.K.2
Park, D.H.3
Jang, Y.O.4
Suk, K.T.5
Yea, C.J.6
Lee, I.Y.7
Kim, J.W.8
Kim, H.S.9
Kwon, S.O.10
Cho, M.Y.11
Ko, S.B.12
Chang, S.J.13
Um, S.H.14
Han, K.H.15
-
85
-
-
77950608186
-
Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats
-
Moreno M, Gonzalo T, Kok RJ, Sancho-Bru P, van Beuge M, Swart J, Prakash J, Temming K, Fondevila C, Beljaars L, Lacombe M, van der Hoeven P, Arroyo V, Poelstra K, Brenner DA, Gines P, Bataller R. Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats. Hepatol 2010;51:942-952
-
(2010)
Hepatol
, vol.51
, pp. 942-952
-
-
Moreno, M.1
Gonzalo, T.2
Kok, R.J.3
Sancho-Bru, P.4
van Beuge, M.5
Swart, J.6
Prakash, J.7
Temming, K.8
Fondevila, C.9
Beljaars, L.10
Lacombe, M.11
van der Hoeven, P.12
Arroyo, V.13
Poelstra, K.14
Brenner, D.A.15
Gines, P.16
Bataller, R.17
-
86
-
-
77049117521
-
Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat
-
Yoshiji H, Noguchi R, Ikenaka Y, Namisaki T, Kitade M, Kaji K, Shirai Y, Yoshii J, Yanase K, Yamazaki M, Tsujimoto T, Kawaratani H, Akahane T, Aihara Y, Fukui H. Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat. BMC Res Notes 2009;2:70
-
(2009)
BMC Res Notes
, vol.2
, pp. 70
-
-
Yoshiji, H.1
Noguchi, R.2
Ikenaka, Y.3
Namisaki, T.4
Kitade, M.5
Kaji, K.6
Shirai, Y.7
Yoshii, J.8
Yanase, K.9
Yamazaki, M.10
Tsujimoto, T.11
Kawaratani, H.12
Akahane, T.13
Aihara, Y.14
Fukui, H.15
-
87
-
-
33644755928
-
Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis
-
Yokohama S, Tokusashi Y, Nakamura K, Tamaki Y, Okamoto S, Okada M, Aso K, Hasegawa T, Aoshima M, Miyokawa N, Haneda M, Yoneda M. Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis. W J Gastro 2006;12:322-326
-
(2006)
W J Gastro
, vol.12
, pp. 322-326
-
-
Yokohama, S.1
Tokusashi, Y.2
Nakamura, K.3
Tamaki, Y.4
Okamoto, S.5
Okada, M.6
Aso, K.7
Hasegawa, T.8
Aoshima, M.9
Miyokawa, N.10
Haneda, M.11
Yoneda, M.12
-
88
-
-
33745204406
-
Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis
-
Nabeshima Y, Tazuma S, Kanno K, Hyogo H, Iwai M, Horiuchi M, Chayama K. Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis. Biochem Biophys Res Commun 2006;346:658-664
-
(2006)
Biochem Biophys Res Commun
, vol.346
, pp. 658-664
-
-
Nabeshima, Y.1
Tazuma, S.2
Kanno, K.3
Hyogo, H.4
Iwai, M.5
Horiuchi, M.6
Chayama, K.7
-
89
-
-
49849093788
-
Liver disease and the renin-angiotensin system: Recent discoveries and clinical implications
-
Lubel JS, Herath CB, Burrell LM, Angus PW. Liver disease and the renin-angiotensin system: recent discoveries and clinical implications. J Gastroenterol Hepatol 2008;23:1327-1338
-
(2008)
J Gastroenterol Hepatol
, vol.23
, pp. 1327-1338
-
-
Lubel, J.S.1
Herath, C.B.2
Burrell, L.M.3
Angus, P.W.4
-
90
-
-
67651192493
-
Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat
-
Lubel JS, Herath CB, Tchongue J, Grace J, Jia Z, Spencer K, Casley D, Crowley P, Sievert W, Burrell LM, Angus PW. Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. Clin Sci (Lond) 2009;117:375-386
-
(2009)
Clin Sci (Lond)
, vol.117
, pp. 375-386
-
-
Lubel, J.S.1
Herath, C.B.2
Tchongue, J.3
Grace, J.4
Jia, Z.5
Spencer, K.6
Casley, D.7
Crowley, P.8
Sievert, W.9
Burrell, L.M.10
Angus, P.W.11
-
91
-
-
70349229376
-
Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice
-
Osterreicher CH, Taura K, De Minicis S, Seki E, Penz-Osterreicher M, Kodama Y, Kluwe J, Schuster M, Oudit GY, Penninger JM, Brenner DA. Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice. Hepatol 2009;50:929-938
-
(2009)
Hepatol
, vol.50
, pp. 929-938
-
-
Osterreicher, C.H.1
Taura, K.2
de Minicis, S.3
Seki, E.4
Penz-Osterreicher, M.5
Kodama, Y.6
Kluwe, J.7
Schuster, M.8
Oudit, G.Y.9
Penninger, J.M.10
Brenner, D.A.11
-
93
-
-
18644369234
-
Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C
-
Terui Y, Saito T, Watanabe H, Togashi H, Kawata S, Kamada Y, Sakuta S. Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C. Hepatol 2002;36:1022
-
(2002)
Hepatol
, vol.36
, pp. 1022
-
-
Terui, Y.1
Saito, T.2
Watanabe, H.3
Togashi, H.4
Kawata, S.5
Kamada, Y.6
Sakuta, S.7
-
94
-
-
31644451945
-
Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: A pilot study
-
Sookoian S, Fernandez MA, Castano G. Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study. W J Gastro 2005;11:7560-7563
-
(2005)
W J Gastro
, vol.11
, pp. 7560-7563
-
-
Sookoian, S.1
Fernandez, M.A.2
Castano, G.3
-
95
-
-
4544342831
-
Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation
-
Rimola A, Londono MC, Guevara G, Bruguera M, Navasa M, Forns X, Garcia-Retortillo M, Garcia-Valdecasas JC, Rodes J. Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation. Transplantation 2004;78:686-691
-
(2004)
Transplantation
, vol.78
, pp. 686-691
-
-
Rimola, A.1
Londono, M.C.2
Guevara, G.3
Bruguera, M.4
Navasa, M.5
Forns, X.6
Garcia-Retortillo, M.7
Garcia-Valdecasas, J.C.8
Rodes, J.9
-
96
-
-
64749115204
-
The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C
-
Corey KE, Shah N, Misdraji J, Abu Dayyeh BK, Zheng H, Bhan AK, Chung RT. The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C. Liver Int 2009;29:748-753
-
(2009)
Liver Int
, vol.29
, pp. 748-753
-
-
Corey, K.E.1
Shah, N.2
Misdraji, J.3
Abu, D.B.K.4
Zheng, H.5
Bhan, A.K.6
Chung, R.T.7
-
97
-
-
70349756901
-
Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C
-
Colmenero J, Bataller R, Sancho-Bru P, Dominguez M, Moreno M, Forns X, Bruguera M, Arroyo V, Brenner DA, Gines P. Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C. Am J Physiol Gastrointest Liver Physiol 2009;297:G726-G734
-
(2009)
Am J Physiol Gastrointest Liver Physiol
, vol.297
-
-
Colmenero, J.1
Bataller, R.2
Sancho-Bru, P.3
Dominguez, M.4
Moreno, M.5
Forns, X.6
Bruguera, M.7
Arroyo, V.8
Brenner, D.A.9
Gines, P.10
-
98
-
-
79952453566
-
The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C trial cohort
-
Abu Dayyeh BK, Yang M, Dienstag JL, Chung RT. The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C trial cohort. Dig Dis Sci 2010;56:564-568
-
(2010)
Dig Dis Sci
, vol.56
, pp. 564-568
-
-
Abu, D.B.K.1
Yang, M.2
Dienstag, J.L.3
Chung, R.T.4
-
99
-
-
0018616738
-
Renin, aldosterone and renal haemodynamics in cirrhosis with ascites
-
Arroyo V, Bosch J, Mauri M, Viver J, Mas A, Rivera F, Rodes J. Renin, aldosterone and renal haemodynamics in cirrhosis with ascites. Eur J Clin Invest 1979;9:69-73
-
(1979)
Eur J Clin Invest
, vol.9
, pp. 69-73
-
-
Arroyo, V.1
Bosch, J.2
Mauri, M.3
Viver, J.4
Mas, A.5
Rivera, F.6
Rodes, J.7
-
100
-
-
0023183830
-
Effects of captopril on renal function in patients with cirrhosis and ascites
-
Daskalopoulos G, Pinzani M, Murray N, Hirschberg R, Zipser RD. Effects of captopril on renal function in patients with cirrhosis and ascites. J Hepatol 1987;4:330-336
-
(1987)
J Hepatol
, vol.4
, pp. 330-336
-
-
Daskalopoulos, G.1
Pinzani, M.2
Murray, N.3
Hirschberg, R.4
Zipser, R.D.5
-
101
-
-
0021907953
-
Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites
-
Pariente EA, Bataille C, Bercoff E, Lebrec D. Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites. Gastroenterology 1985;88:1255-1259
-
(1985)
Gastroenterology
, vol.88
, pp. 1255-1259
-
-
Pariente, E.A.1
Bataille, C.2
Bercoff, E.3
Lebrec, D.4
-
102
-
-
0027528296
-
Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver
-
Gentilini P, Romanelli RG, La Villa G, Maggiore Q, Pesciullesi E, Cappelli G, Casini Raggi V, Foschi M, Marra F, Pinzani M. Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. Gastroenterology 1993;104:588-594
-
(1993)
Gastroenterology
, vol.104
, pp. 588-594
-
-
Gentilini, P.1
Romanelli, R.G.2
la Villa, G.3
Maggiore, Q.4
Pesciullesi, E.5
Cappelli, G.6
Casini, R.V.7
Foschi, M.8
Marra, F.9
Pinzani, M.10
-
103
-
-
0036617271
-
Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells
-
Yoshiji H, Yoshii J, Ikenaka Y, Noguchi R, Yanase K, Tsujinoue H, Imazu H, Fukui H. Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells. Int J Oncol 2002;20:1227-1231
-
(2002)
Int J Oncol
, vol.20
, pp. 1227-1231
-
-
Yoshiji, H.1
Yoshii, J.2
Ikenaka, Y.3
Noguchi, R.4
Yanase, K.5
Tsujinoue, H.6
Imazu, H.7
Fukui, H.8
-
104
-
-
0037963091
-
Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor
-
Yoshiji H, Kuriyama S, Fukui H. Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Tumour Biol 2002;23:348-356
-
(2002)
Tumour Biol
, vol.23
, pp. 348-356
-
-
Yoshiji, H.1
Kuriyama, S.2
Fukui, H.3
-
105
-
-
67649158636
-
Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma
-
Yoshiji H, Noguchi R, Toyohara M, Ikenaka Y, Kitade M, Kaji K, Yamazaki M, Yamao J, Mitoro A, Sawai M, Yoshida M, Fujimoto M, Tsujimoto T, Kawaratani H, Uemura M, Fukui H. Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma. J Hepatol 2009;51:315-321
-
(2009)
J Hepatol
, vol.51
, pp. 315-321
-
-
Yoshiji, H.1
Noguchi, R.2
Toyohara, M.3
Ikenaka, Y.4
Kitade, M.5
Kaji, K.6
Yamazaki, M.7
Yamao, J.8
Mitoro, A.9
Sawai, M.10
Yoshida, M.11
Fujimoto, M.12
Tsujimoto, T.13
Kawaratani, H.14
Uemura, M.15
Fukui, H.16
-
106
-
-
0032146551
-
Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors
-
Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998;102:538-549
-
(1998)
J Clin Invest
, vol.102
, pp. 538-549
-
-
Iredale, J.P.1
Benyon, R.C.2
Pickering, J.3
McCullen, M.4
Northrop, M.5
Pawley, S.6
Hovell, C.7
Arthur, M.J.8
-
107
-
-
0347986777
-
NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis
-
Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J, Qian T, Schoonhoven R, Hagedorn CH, Lemasters JJ, Brenner DA. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 2003;112:1383-1394
-
(2003)
J Clin Invest
, vol.112
, pp. 1383-1394
-
-
Bataller, R.1
Schwabe, R.F.2
Choi, Y.H.3
Yang, L.4
Paik, Y.H.5
Lindquist, J.6
Qian, T.7
Schoonhoven, R.8
Hagedorn, C.H.9
Lemasters, J.J.10
Brenner, D.A.11
-
108
-
-
33845476271
-
Angiotensin II and Aldosterone stimulating NF-kappaB and AP-1 activation in hepatic fibrosis of rat
-
Li X, Meng Y, Wu P, Zhang Z, Yang X. Angiotensin II and Aldosterone stimulating NF-kappaB and AP-1 activation in hepatic fibrosis of rat. Regul Pept 2007;138:15-25
-
(2007)
Regul Pept
, vol.138
, pp. 15-25
-
-
Li, X.1
Meng, Y.2
Wu, P.3
Zhang, Z.4
Yang, X.5
-
109
-
-
18844457924
-
Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression
-
Kanno K, Tazuma S, Nishioka T, Hyogo H, Chayama K. Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression. Dig Dis Sci 2005;50:942-948
-
(2005)
Dig Dis Sci
, vol.50
, pp. 942-948
-
-
Kanno, K.1
Tazuma, S.2
Nishioka, T.3
Hyogo, H.4
Chayama, K.5
-
110
-
-
77957864977
-
Angiotensin II induces tumor progression and fibrosis in intrahepatic cholangiocarcinoma through an interaction with hepatic stellate cells
-
Okamoto K, Tajima H, Ohta T, Nakanuma S, Hayashi H, Nakagawara H, Onishi I, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Tani T, Fujimura T, Kayahara M, Harada S, Wakayama T, Iseki S. Angiotensin II induces tumor progression and fibrosis in intrahepatic cholangiocarcinoma through an interaction with hepatic stellate cells. Int J Oncol 2010;37:1251-1259
-
(2010)
Int J Oncol
, vol.37
, pp. 1251-1259
-
-
Okamoto, K.1
Tajima, H.2
Ohta, T.3
Nakanuma, S.4
Hayashi, H.5
Nakagawara, H.6
Onishi, I.7
Takamura, H.8
Ninomiya, I.9
Kitagawa, H.10
Fushida, S.11
Tani, T.12
Fujimura, T.13
Kayahara, M.14
Harada, S.15
Wakayama, T.16
Iseki, S.17
|